Search research articles
Contact Us
Filters
Showing results (241-250 of 251) with videos related to
Page
of 26
Sort By:
Annales De Dermatologie Et De Venereologie
|
May 12, 2005
[The prospective multicenter study on standard photopatch tests by the French Society of Photodermatology from 1991-2001]
F Leonard, H Adamski, A Bonnevalle, et al.
Breast Cancer Research and Treatment
|
June 19, 2010
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study
Janine L Mansi, Ann Yellowlees, Julian Lipscombe, et al.
Annales De Dermatologie Et De Venereologie
|
May 19, 2019
[Phototesting in France: A survey by French Society for Photodermatology]
A Moreau, M Avenel-Audran, H Adamski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2005
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study
T R Jeffry Evans, Ann Yellowlees, Elizabeth Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2018
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data
Matteo Lambertini, Halle C F Moore, Robert C F Leonard, et al.
The New England Journal of Medicine
|
November 3, 2006
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
Christopher J Poole, Helena M Earl, Louise Hiller, et al.
British Journal of Cancer
|
October 11, 2012
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials
H M Earl, L Hiller, J A Dunn, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 12, 2023
Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
Elizabeth Roof, Cheri L Deal, Shawn E McCandless, et al.
The Review of Scientific Instruments
|
October 3, 2014
An apparatus to manipulate and identify individual Ba ions from bulk liquid Xe
K Twelker, S Kravitz, M Montero Díez, et al.
Physical Review Letters
|
August 7, 2012
Search for neutrinoless double-beta decay in 136Xe with EXO-200
M Auger, D J Auty, P S Barbeau, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 251) with videos related to
Sort By:
Page
of 26
Annales De Dermatologie Et De Venereologie
|
May 12, 2005
[The prospective multicenter study on standard photopatch tests by the French Society of Photodermatology from 1991-2001]
F Leonard, H Adamski, A Bonnevalle, et al.
Breast Cancer Research and Treatment
|
June 19, 2010
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study
Janine L Mansi, Ann Yellowlees, Julian Lipscombe, et al.
Annales De Dermatologie Et De Venereologie
|
May 19, 2019
[Phototesting in France: A survey by French Society for Photodermatology]
A Moreau, M Avenel-Audran, H Adamski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2005
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study
T R Jeffry Evans, Ann Yellowlees, Elizabeth Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2018
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data
Matteo Lambertini, Halle C F Moore, Robert C F Leonard, et al.
The New England Journal of Medicine
|
November 3, 2006
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
Christopher J Poole, Helena M Earl, Louise Hiller, et al.
British Journal of Cancer
|
October 11, 2012
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials
H M Earl, L Hiller, J A Dunn, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 12, 2023
Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
Elizabeth Roof, Cheri L Deal, Shawn E McCandless, et al.
The Review of Scientific Instruments
|
October 3, 2014
An apparatus to manipulate and identify individual Ba ions from bulk liquid Xe
K Twelker, S Kravitz, M Montero Díez, et al.
Physical Review Letters
|
August 7, 2012
Search for neutrinoless double-beta decay in 136Xe with EXO-200
M Auger, D J Auty, P S Barbeau, et al.
Page
of 26